A photo of Adrienne M. Hammill.

Research Director, Hemangioma & Vascular Malformation Program

Associate Professor, UC Department of Pediatrics



Board Certified

My Biography & Research


Dr. Adrienne M. Hammill is trained in pediatrics and hematology/oncology and is particularly interested in bringing new and/or better medical therapy options to the treatment of vascular anomalies. She is one of the medical physicians for the Hemangioma and Vascular Malformations team. She obtained her schooling at the University of Texas Southwestern and completed her residency and fellowship here at Cincinnati Children’s Hospital Medical Center. She is a dedicated professional and strives to improve the treatment for her patients. Cincinnati Children’s has been named a site for the brain vascular malformations consortium, which is a clinical research group funded by National Institutes of Health and the rare disease network and more recently a SWF Center of Excellence. She has developed a broader interest in Brain Vascular Malformations, and now heads our HHT Center and participates in the Cerebrovascular Clinic housed in Neurosurgery as well.

Clinical Interests

Hemangiomas and vascular malformations; genetic predispositions to cancer

Academic Affiliation

Associate Professor, UC Department of Pediatrics


Hereditary Hemorrhagic Telangiectasia, Cerebrovascular, Cancer and Blood Diseases, Hemangioma and Vascular Malformations, Sturge-Weber Syndrome, Oncology, Cancer and Blood Diseases, Hematology

My Locations

My Education

MD: University of Texas Southwestern Medical School, Dallas, TX, 2004.

PhD: University of Texas Southwestern Graduate School of Biomedical Sciences, Dallas, TX, 2004.

Residency: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.

Fellowship: Cincinnati Children’s Hospital Medical Center.

Certifications: Pediatrics, 2008; Pediatric Hematology Oncology, 2011.

My Publications

Signaling pathways and inhibitors of cells from patients with kaposiform lymphangiomatosis. Boscolo, E; Pastura, P; Glaser, K; Goines, J; Hammill, AM; Adams, DM; Dickie, P; Dickie, BH; Le Cras, TD. Pediatric Blood and Cancer. 2019; 66.

Physical and Family History Variables Associated With Neurological and Cognitive Development in Sturge-Weber Syndrome. Day, AM; McCulloch, CE; Hammill, AM; Juhasz, C; Lo, WD; Pinto, AL; Miles, DK; Fisher, BJ; Ball, KL; Wilfong, AA; et al. Pediatric Neurology. 2019; 96:30-36.

Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease. Ricci, KW; Hammill, AM; Mobberley-Schuman, P; Nelson, SC; Blatt, J; Bender, JL G; McCuaig, CC; Synakiewicz, A; Frieden, IJ; Adams, DM. Pediatric Blood and Cancer. 2019; 66:e27614-e27614.

Surgical resection of infantile hemangiomas following medical treatment with propranolol versus corticosteroids. Polites, SF; Watanabe, M; Crafton, T; Jenkins, TM; Alvarez-Allende, CR; Hammill, AM; Dasgupta, R. Journal of Pediatric Surgery. 2019; 54:740-743.

Hypothesis: Presymptomatic treatment of Sturge-Weber Syndrome With Aspirin and Antiepileptic Drugs May Delay Seizure Onset. Day, AM; Hammill, AM; Juhasz, C; Pinto, AL; Roach, ES; McCulloch, CE; Comi, AM; Ball, KL; Fisher, BJ; Koenig, JI; et al. Pediatric Neurology. 2019; 90:8-12.

Evidence of Normal Alveolar Size in Pediatric Generalized Lymphatic Anomaly. Walkup, LL; Towe, CT; Bdaiwi, A; Merrow, AC; Hammill, AM; Cleveland, ZI; Woods, JC. American Journal of Respiratory and Critical Care Medicine. 2018; 198:1573-1574.

A xenograft model for venous malformation. Goines, J; Li, X; Cai, Y; Mobberley-Schuman, P; Metcalf, M; Fishman, SJ; Adams, DM; Hammill, AM; Boscolo, E. Angiogenesis. 2018; 21:725-735.

Sclerotherapy for intramuscular vascular malformations: A single-center experience. Scorletti, F; Patel, MN; Hammill, AM; Ricci, KW; Myer, CM; Dasgupta, R. Journal of Pediatric Surgery. 2018; 53:1056-1059.

Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies. Mizuno, T; Emoto, C; Fukuda, T; Hammill, AM; Adams, DM; Vinks, AA. European Journal of Pharmaceutical Sciences. 2017; 109S:S124-S131.

Infant skin maturation: Preliminary outcomes for color and biomechanical properties. Visscher, MO; Burkes, SA; Adams, DM; Hammill, AM; Wickett, RR. Skin Research and Technology. 2017; 23:545-551.